Anika Therapeutics (ANIK) Intangibles (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Intangibles of $1.7 million for Q2 2026, down 89.2% year-over-year from $15.7 million in Q2 2025, and little changed quarter-over-quarter from $1.7 million in Q1 2026.
Anika Therapeutics (ANIK) Intangibles (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Intangibles for 17 consecutive years, with $1.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Intangibles fell 89.2% year-over-year to $1.7 million; the TTM figure through Jun 2026 stood at $1.7 million (down 89.2% YoY), while the FY2025 annual figure was $1.7 million, up 183.33% from the prior year.
- Intangibles held at $1.7 million in Q2 2026 per ANIK's latest filing, from $1.7 million in the prior quarter.
- Across five years, Intangibles topped out at $112.1 million in Q1 2022 and bottomed at $600000.0 in Q4 2024.
- Historically, Intangibles has averaged $55.2 million across 5 years, with a median of $49.9 million in 2024.
- Annual changes were most pronounced in 2024 — Intangibles sank 96.98% — and 2025, when it soared 183.33%.
- Anika Therapeutics' Intangibles stood at $112.1 million in 2022, then sank by 82.31% to $19.8 million in 2023, then tumbled by 96.98% to $600000.0 in 2024, then jumped by 183.33% to $1.7 million in 2025, then changed by 0.0% to $1.7 million in 2026.
- Business Quant data shows ANIK's Intangibles at $1.7 million in Q2 2026, $1.7 million in Q1 2026, and $1.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 1.12 Bn |
| 10 | Anika Therapeutics | 285.40 Mn | 246.98 Mn | 21.24 Mn | 1.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.70 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Sep 30, 2025 | 15.74 Mn |
| Jun 30, 2025 | 15.74 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | 600,000.00 |
| Sep 30, 2024 | 49.95 Mn |
| Jun 30, 2024 | 49.95 Mn |
| Mar 31, 2024 | 49.95 Mn |
| Dec 31, 2023 | 19.84 Mn |
| Sep 30, 2023 | 112.14 Mn |
| Jun 30, 2023 | 112.14 Mn |
| Mar 31, 2023 | 112.14 Mn |
| Dec 31, 2022 | 112.14 Mn |
| Sep 30, 2022 | 112.14 Mn |
| Jun 30, 2022 | 112.14 Mn |
| Mar 31, 2022 | 112.14 Mn |
| Dec 31, 2021 | 112.74 Mn |
| Sep 30, 2021 | 112.74 Mn |